Caricamento...
Cryptococcemia in a patient with COVID‐19: A case report
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID‐19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
Salvato in:
| Pubblicato in: | Clin Case Rep |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869327/ https://ncbi.nlm.nih.gov/pubmed/33598258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3668 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|